Indian-Origin CFO Aditya Humad Gets Four-Month Jail Term in US Surgeon Bribery Case

Indian-origin former chief financial officer Aditya Humad has been sentenced to four months in federal prison in the United States for his role in a kickback scheme involving surgeons and a spinal implant company. Humad, 41, who lives in Cambridge, Massachusetts, was sentenced by US District Judge Indira Talwani after pleading guilty to conspiracy to violate the federal Anti-Kickback Statute. In addition to the four-month prison term, he has been ordered to serve one year of supervised release and pay a $9,500 fine.

The case is linked to SpineFrontier, a company that manufactures spinal implant devices. According to the US Department of Justice, Humad was involved in arrangements under which surgeons received payments described as consulting fees. Prosecutors said the agreements were used to disguise payments intended to encourage doctors to use SpineFrontier products during spinal procedures.

Investigators found that more than $540,000 was paid to surgeons through these arrangements. The consulting agreements offered doctors payments ranging from $250 to $1,000 an hour for providing technical feedback on the company's products. However, prosecutors said several doctors performed little or none of the consulting work for which they were paid.

The government alleged that the payments were designed to influence surgeons' decisions when selecting spinal devices for their patients. Some of the surgeries in which the company's products were used were reimbursed through federal healthcare programmes, including Medicare, Medicaid and the Veterans Health Administration.

According to prosecutors, the arrangement helped SpineFrontier generate millions of dollars in revenue from surgeries involving its products. The case therefore raised concerns over whether financial incentives were being used to influence medical decisions involving federally funded healthcare programmes. Humad was initially charged in 2021 along with SpineFrontier founder, president and chief executive officer Kingsley R. Chin. The investigation subsequently resulted in criminal and civil proceedings involving company executives, the business and physicians who received payments.

The Justice Department said the broader investigation has resulted in more than $4 million being recovered through criminal and civil actions. Several physicians also reached settlements with the government over allegations involving payments connected to consulting arrangements. Humad pleaded guilty in May 2026, accepting responsibility for his role in the conspiracy. His sentencing adds another development to the long-running federal investigation into the medical-device company.

The case also highlights the importance of the US Anti-Kickback Statute, which prohibits financial arrangements intended to improperly influence referrals or the use of healthcare services and products paid for by federal healthcare programmes. While medical-device companies can legally compensate doctors for legitimate consulting services, such agreements must involve genuine work and cannot be structured as disguised incentives for using particular products.

US authorities have continued to increase scrutiny of financial relationships between healthcare companies and medical professionals, particularly when federal healthcare funds are involved. The Humad case serves as another example of how payments presented as legitimate business arrangements can lead to criminal prosecution when prosecutors determine that they were actually used to influence medical decisions.